BEHANDLUNG VON SCHIZOPHRENIE

European patent · EP3703695 · In force

Register entry

Publication number
EP3703695
Application number
EP18806981
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Nov 5, 2018
Published
Sep 9, 2020
Granted
Dec 21, 2022
Protection ends at the latest
Nov 4, 2038
Next annual fee due
Nov 30, 2026
IPC classes
A61K 31/496 (2006.01)
A61P 25/18 (2006.01)
Priority
US 201762581249 P 03.11.2017
PCT application
PCT/EP2018/080154 05.11.2018
PCT publication
WO2019/086661 09.05.2019
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Dec 1, 2025

    Change

    Published in Swissreg on 01.12.2025

  2. Dec 1, 2024

    Change

    Published in Swissreg on 01.12.2024

  3. Dec 1, 2023

    Change

    Published in Swissreg on 01.12.2023

  4. Nov 9, 2023

    Change

    Published in Swissreg on 09.11.2023

  5. Dec 21, 2022

    Granted

    Published in Swissreg on 21.12.2022

  6. Dec 21, 2022

    Agent entered

    Representative
    MICHELI & CIE SA, 122, rue de Genève,, CP 61, 1226 Thônex

    Published in Swissreg on 21.12.2022

Parties

Holder

PIERRE FABRE MEDICAMENT

81500 Lavaur, FR

Agent

MICHELI & CIE SA

122, rue de Genève, CP 61, 1226 Thônex

Inventor

TONNER, Françoise

31000 Toulouse, FR

MUCCI, Armida

80138 Naples, IT

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.